MariMed Inc (MRMD)
0.2149
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
MariMed Cash from Investing (Quarterly): -4.266M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.266M |
| December 31, 2023 | -6.348M |
| September 30, 2023 | -6.215M |
| June 30, 2023 | -6.497M |
| March 31, 2023 | -6.925M |
| December 31, 2022 | -2.513M |
| September 30, 2022 | -2.624M |
| June 30, 2022 | -16.73M |
| March 31, 2022 | -4.377M |
| December 31, 2021 | -3.219M |
| September 30, 2021 | -4.91M |
| June 30, 2021 | -5.618M |
| March 31, 2021 | -2.877M |
| December 31, 2020 | -0.5353M |
| September 30, 2020 | -1.359M |
| June 30, 2020 | -1.215M |
| March 31, 2020 | -1.354M |
| December 31, 2019 | -3.255M |
| September 30, 2019 | -3.852M |
| June 30, 2019 | -3.396M |
| March 31, 2019 | -2.034M |
| December 31, 2018 | -25.69M |
| September 30, 2018 | -8.639M |
| June 30, 2018 | -4.457M |
| March 31, 2018 | -1.284M |
| Date | Value |
|---|---|
| December 31, 2017 | -9.45M |
| September 30, 2017 | -7.732M |
| June 30, 2017 | -1.944M |
| March 31, 2017 | -1.797M |
| December 31, 2016 | -0.0102M |
| September 30, 2016 | -1.829M |
| June 30, 2016 | -0.5173M |
| March 31, 2016 | -0.9835M |
| December 31, 2015 | -0.9273M |
| September 30, 2015 | -0.1928M |
| June 30, 2015 | -0.9769M |
| March 31, 2015 | -1.408M |
| December 31, 2014 | -0.0003M |
| September 30, 2014 | -0.4024M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.023M |
| December 31, 2013 | 0.0038M |
| September 30, 2013 | 0.0068M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.0172M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-16.73M
Minimum
Jun 2022
-0.5353M
Maximum
Dec 2020
-4.404M
Average
-3.624M
Median
Cash from Investing (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -10.80M |
| Zymeworks Inc | -7.316M |
| Viemed Healthcare Inc | -5.365M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.21M |
| Cash from Financing (Quarterly) | 1.645M |
| Free Cash Flow | -5.117M |
| Free Cash Flow Per Share (Quarterly) | -0.0011 |
| Free Cash Flow to Equity (Quarterly) | -2.553M |
| Free Cash Flow to Firm (Quarterly) | -5.627M |
| Free Cash Flow Yield | -6.41% |